Literature DB >> 8951752

Local delivery of heparin with balloon angioplasty: results of a prospective randomized trial.

R C Sheley1, E S Schuman, B A Standage, J W Ragsdale, P D Feliciano, S F Quinn.   

Abstract

PURPOSE: To evaluate the effectiveness of local delivery of heparin via hydrogel-coated balloons in the treatment of vascular stenoses associated with hemodialysis access.
MATERIALS AND METHODS: This was a randomized, prospective trial comparing treatment with hydrogel-coated balloon catheters delivered with heparin coating (n = 33) and without (n = 26). All patients were undergoing hemodialysis, and all stenoses involved the venous anastomosis of a dialysis graft or a native vein. The heparin-treated balloons were soaked in concentrated heparin and delivered in a protected manner to help prevent washout of heparin.
RESULTS: The mean primary patencies were 143 days with heparin treatment and 214 days without heparin (P = .174). The mean assisted primary patencies were 165 days with heparin and 194 days without (P = .315). The mean secondary patencies were 351 days with heparin and 384 without (P = .81).
CONCLUSION: In this population with this technique, the treatment outcome of venous outflow stenosis in patients with dialysis grafts is not improved with local delivery of heparin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951752     DOI: 10.1016/s1051-0443(96)70860-6

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  2 in total

Review 1.  Dialysis Access Anatomy and Interventions: A Primer.

Authors:  Charles Martin; Rex Pillai
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

Review 2.  Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Authors:  Pietro Ravani; Robert R Quinn; Matthew J Oliver; Divya J Karsanji; Matthew T James; Jennifer M MacRae; Suetonia C Palmer; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2016-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.